Related Experiment Video
Updated: Apr 16, 2026
06:15
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
28.0K
Vonoprazan: first global approval
1Springer, Private Bag 65901, Mairangi Bay, 0754, Auckland, New Zealand, dru@adis.com.
Drugs
|March 7, 2015
Summary
Vonoprazan, a potassium-competitive acid blocker (P-CAB), is approved in Japan for treating acid-related conditions. Its development milestones are summarized, highlighting its journey to this significant regulatory approval.
Area of Science:
- Pharmacology
- Gastroenterology
- Drug Development
Background:
- Vonoprazan is an orally bioavailable potassium-competitive acid blocker (P-CAB).
- It is developed by Takeda for managing and preventing acid-related gastrointestinal diseases.
- Acid-related conditions represent a significant global health burden, necessitating novel therapeutic agents.
Purpose of the Study:
- To summarize the key developmental milestones of vonoprazan.
- To document the drug's progression leading to its initial regulatory approval.
- To provide an overview of vonoprazan's therapeutic applications in acid-related diseases.
Main Methods:
- Review of clinical development phases (Phase I, III).
- Analysis of regulatory submissions and approvals.
- Compilation of data on vonoprazan's efficacy and safety profile.
Main Results:
- Vonoprazan received approval in Japan for treating various acid-related diseases.
- Indications include erosive esophagitis, ulcers, GERD, and H. pylori eradication.
- Phase III trials are ongoing for NSAID-associated ulcer recurrence prevention.
Conclusions:
- Vonoprazan represents a significant advancement in P-CAB therapy.
- Its development journey culminated in a crucial approval for acid-related disorders.
- Further development is anticipated for expanded therapeutic indications.
Related Concept Videos
01:26FDA Approved Drugs: Changes to Approved Drugs
336
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
336
01:26Drug Administration and Therapy Phases: Overview
2.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
2.1K
01:02Prescription, Nonprescription and Orphan Drugs
1.4K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K
01:19Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
1.2K
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
1.2K
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
4.7K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.7K